Kymera Therapeutics Inc (KYMR)
$126.63 +3.29% Close Oct 30, 2026 Live
Kymera Therapeutics stock today
Kymera Therapeutics closed at $126.63 on October 30, 2026, up 3.29% on the day. Over the past year it returned +106.1% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $10.5 billion.
$60.00$80.00$100.00$120.00
NovJan 2026MarMayJulSep
| Period | KYMR | S&P 500 (SPY) |
|---|---|---|
| 1 month | +13.3% | -0.9% |
| 3 months | +18.3% | +2.1% |
| Year to date | +62.7% | +11.7% |
| 1 year | +106.1% | +12.4% |
| 3 years | +1,029% | +88.5% |
| 5 years | +115.1% | +76.0% |
Key statistics
- Market value
- $10.5B
- Price / sales
- 103.0
- 52-week range
- $58.66 to $127.31
About Kymera Therapeutics
Kymera Therapeutics discovers and develops small-molecule protein degradation drugs for cancer and autoimmune diseases.
Sector: Health Care
More on Kymera Therapeutics
- Financials: revenue, earnings and segmentsRevenue -17% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $2,151 today
No forecast, no recommendation. This page describes Kymera Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.